LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2023. The put-call ratio across all filers is 3.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9 | -30.8% | 6,005 | 0.0% | 0.00% | – |
| Q1 2024 | $13 | -56.7% | 6,005 | -60.7% | 0.00% | – |
| Q4 2023 | $30 | +20.0% | 15,291 | -10.5% | 0.00% | – |
| Q3 2023 | $25 | -53.7% | 17,078 | 0.0% | 0.00% | – |
| Q2 2023 | $54 | +28.6% | 17,078 | -4.6% | 0.00% | – |
| Q1 2023 | $42 | -45.5% | 17,903 | -19.1% | 0.00% | -100.0% |
| Q4 2022 | $77 | -100.0% | 22,128 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $162,000 | +13.3% | 22,128 | +1.0% | 0.00% | +100.0% |
| Q2 2022 | $143,000 | +28.8% | 21,912 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $111,000 | – | 21,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WuXi AppTec Co., Ltd. | 7,682,156 | $11,139,126 | 47.74% |
| MWG Management Ltd. | 20,162,332 | $29,235,381 | 31.93% |
| Orland Properties Ltd | 15,093,969 | $21,886,255 | 16.63% |
| Foresite Capital Management IV, LLC | 8,325,000 | $12,071,250 | 8.11% |
| Opaleye Management Inc. | 1,670,000 | $2,421,500 | 0.55% |
| MIC Capital Management UK LLP | 1,740,569 | $2,523,825 | 0.55% |
| Alphabet Inc. | 5,865,125 | $8,504,431 | 0.43% |
| HSG Holding Ltd | 3,045,997 | $4,995,435 | 0.18% |
| Orbimed Advisors | 6,405,098 | $9,287,392 | 0.18% |
| Ikarian Capital, LLC | 526,066 | $762,796 | 0.13% |